Paul Laidler has over 25 years' pharmaceutical development experience having held several roles within large Pharma companies including AstraZeneca and a number of rapidly developing biotechnology companies including PowderJect Technologies, Chiron Vaccines, PowderMed and most recently Circassia Pharmaceuticals. Prior to setting up as an independent consultant, Dr Laidler was Vice President of Pharmaceutical Sciences at Circassia Pharmaceuticals.

Dr Laidler received both his Bachelor of Pharmacy and PhD degrees from King’s College London.